StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
300203.SZ$12.34-0.88%
Fair $12.34+0.0%

300203.SZ

300203.SZ

Technology / Scientific & Technical InstrumentsShenzhen

$12.34

-0.11 (-0.88%)

Fairly Valued+0.0%Fair Value $12.34Fund rank 24/100 · Data gapFallback financials|
SA 11/F
F-Score: 2/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 17%

FCF escenarios

weak_data · normalized FCF $313.3M · quality 35.3/100

Data gap 24/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 20/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

11/100

F

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -8.7%, below the 5% threshold
Thesis & Journal · 300203.SZLocal privado en este navegador · 300203.SZ
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$0

P/E

N/A

•

EV/EBITDA

164.2x

↑

ROE

-8.7%

↓

Gross Margin

38.1%

↑

Debt/Equity

1.15

↑
52-Week Range$12
$12$24

TradingView lightweight chart

300203.SZ price, volumen y niveles de valoración

Último $12.34Periodo -42.4%
Fair value: $12.34

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-4.6%

FCF CAGR

—

FCF margin

10.5%

FCF / Net income

-1.35x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $3.00B · net income $-232.6M · FCF $313.3M

2022-FY → 2025-FY

Gross margin

38.1%+0.8% pts

Operating margin

-1.9%+1.6% pts

Net margin

-7.8%+3.1% pts

FCF margin

10.5%+14.6% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$3.00B$3.00B$3.61B$3.18B$3.45B
Net Income$-232.6M$-232.6M$206.9M$-322.6M$-374.8M
EBITDA$45.2M$45.2M$596.0M$-48.3M$-179.0M
EPS-0.52-0.520.46-0.72-0.84
Gross Margin38.1%38.1%44.4%41.1%37.3%
Operating Margin-1.9%-1.9%12.5%-3.4%-3.5%
Net Margin-7.8%-7.8%5.7%-10.1%-10.9%
Balance Sheet
Debt/Equity1.151.151.061.251.17
Current Ratio1.261.26———
Cash Flow
Free Cash Flow$313.3M$313.3M$578.1M$153.1M$-143.9M
Returns
ROE-8.7%-8.7%6.6%-11.1%-11.6%
Valuation
P/E——30.65——
EV/EBITDA164.16164.1613.83——
P/B2.072.072.042.314.92
Growth & Yield
Revenue Growth-17.1%-17.1%13.6%-7.8%—
EPS Growth-213.0%-213.0%163.9%14.3%—
Dividend Yield1.6%1.6%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -37.4%

Total return

-37.4%

Start / end P/E

n/dx → n/dx

EPS bridge

0.46 → -0.52

Residual

-39.1%

EPS growthn/d
Multiple reratingn/d
Dividend+1.6%
Residual / FX / buybacks / cross-term-39.1%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.